EFPIA statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools

Following the EU Commission President von der Leyen's intervention at today's World Health Organisation gathering of world leaders and key partners, we reiterate the European research-based pharmaceutical industry's unwavering commitment to playing its role in the global fight against COVID-19.

Our researchers and scientists are working around the clock to accelerate the research and development of vaccines, diagnostics and therapeutics for use against COVID-19 and to expanding our manufacturing capabilities and sharing available capacity to ramp up production once a successful medicine or vaccine is developed. And to make them available and affordable to the patients and citizens that need them.

This pandemic transcends borders and we stand in solidarity and unity with citizens, governments, health systems and key partners in research to tackle the coronavirus.